POLARITYTE, INC. (NASDAQ:COOL) Files An 8-K Regulation FD Disclosure

0

POLARITYTE, INC. (NASDAQ:COOL) Files An 8-K Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure

PolarityTE, Inc. (the Company) has made available a presentation
about its business, a copy of which is filed as Exhibit 99.1 to
this Current Report on Form 8-K (the Report) and is hereby
incorporated by reference.

The information contained in the presentation is summary
information that should be considered in the context of the
Companys filings with the Securities and Exchange Commission and
other public announcements the Company may make by press release
or otherwise from time to time. The presentation speaks as of the
date of this Report. While the Company may elect to update the
presentation in the future to reflect events and circumstances
occurring or existing after the date of this Report, the Company
specifically disclaims any obligation to do so.

The presentation contains forward-looking statements, and as a
result, investors should not place undue reliance on these
forward-looking statements.

The information set forth in this Report, including without
limitation the presentation, is not deemed filed for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended
(the Exchange Act), or incorporated by reference in any filing
under the Securities Act of 1933, as amended, or the Exchange
Act, except as may be expressly set forth by specific reference
in such a filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

The exhibits listed in the following Exhibit Index are filed as
part of this Current Report on Form 8-K.

Exhibit No. Description
99.1 PolarityTE, Inc. presentation dated June 2017



POLARITYTE, INC. Exhibit

To view the full exhibit click here
About POLARITYTE, INC. (NASDAQ:COOL)

PolarityTE, Inc., formerly Majesco Entertainment Company, is a technology company. The Company has developed, marketed, published and distributed software through online platforms. The Company develops applications for gaming on computers, handheld devices and game consoles. The Company is the owner of patent applications and know-how related to regenerative medicine and tissue engineering, as well as software applications used in diagnosis and treatment related to regenerative medicine. It seeks to develop and obtain regulatory approval for technology that will utilize a patient’s own tissue substrates for the regeneration of skin, bone, muscle, cartilage, fat, blood vessels and nerves. Its PolarityTE platform simplifies regeneration and allows cells to function naturally. The platform can be applied across all cells, tissues and composite structures. Its platform induces cell and tissue polarity, and creates functional tissue that mirrors natural development in the human body.